Dell seeks to personalize cancer treatments through genomics, EHRs

Dell is building infrastructure to support electronic health records and genomics in an effort to make care more personalized, according to an article published this week in InformationWeek Healthcare. Jamie Coffin, vice president and general manager of Dell Healthcare and Life Sciences, told the publication that EHRs are a good fit to manage the genomic data needed to personalize care. "As you know, you can't keep your genome in a folder behind your desk," he said. "This becomes the new model for genomic medicine." Specifically, the infrastructure will be used in a project aimed at personalizing care for pediatric cancer patients. Article

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.